Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers

Virus Research

Volumn 60, Issue 1, 1999, Pages 41-54

  Fischer, Nicole ^a   Kopper, Bernd ^a   Graf, Norbert ^b   Schlehofer, Jörg R ^c   Grässer, Friedrich A ^a   Mueller Lantzsch, Nikolaus ^a  

^a Abt Virologie Haus 47 U   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Epstein Barr virus; Functional analyses of different LMP1 isolates; LMP1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; TRANSCRIPTION FACTOR AP 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; EPSTEIN BARR VIRUS; GENE MUTATION; GENE SEQUENCE; HODGKIN DISEASE; MARMOSET; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; CALLITHRIX; CARRIER STATE; CELL LINE; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MICE; NF-KAPPA B; RATS; TRANSCRIPTION FACTOR AP-1; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; RODENTIA;

EID: 0033014959     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(98)00147-6     Document Type: Article

References (44)

1. Angel P., Hattori K., Smeal T., Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 55:1988;875-885.
2. Arenzana-Seidedos F., Fernandez B., Dominguez I., Jaque J.M., Thomas D., Diaz-Meco M.T., Moscat J., Virelizier J.L. Phosphatidylcholine hydrolysis activates NF-κB and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. J. Virol. 67:1993;6596-6604.
3. Baichwal V.R., Sugden B. The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene. 4:1989;67-74.
4. Bolivar F., Bachman K. Plasmids of E. coli as cloning vectors. Methods Enzymol. 68:1977;244-267.
5. Botchan M., Topp W., Sambrook J. The arrangement of simian virus 40 sequences in the DNA of transformed cells. Cell. 9:1976;269-287.
6. Chen M.L., Tsai N., Liang L., Shu C.H., Huang C.R., Sulitzeanu D., Lie S.T., Chang Y.S. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene. 7:1992;2131-2140.
7. Cheung S.T., Leung S.F., Chiu K.W., Tam J.S., Fok T.F., Johnson P.J., Huang D.P. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int. J. Cancer. 76:1998;399-406.
8. Devergne O., Hatzivassiliou H., Izumi K., Kaye K.M., Klejinen M.F., Kieff E., Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16:1996;7098-7108.
9. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16:1997;6131-6140.
10. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed with human adenovirus type 5. J. Gen. Virol. 36:1977;59-72.
11. Green S., Issemann I., Sheer E.A. Versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:1988;369.
12. Hammerschmidt W., Sugden B., Baichwal V.R. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63:1989;2469-2475.
13. Hammerskjold M., Simurda M. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeats through induction of NF-κB activity. J. Virol. 66:1992;6496-6501.
14. Herr I., van Dam H., Angel P. Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis. 15:1994;1105-1113.
15. Hu L.F., Zabarovsky E.R., Chen F., Cao S.L., Ernberg I., Klein G., Winberg G. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. Gen. Virol. 72:1991;2399-2409.
16. Huen D., Henderson S., Croom-Carter D., Rowe M. The Epstein-Barr virus LMP1 mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 10:1995;549-560.
17. Izumi K.M., Kieff E. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA. 94:1997;12592-12597.
18. Izumi K.M., Kaye K.M., Kieff E. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 94:1997;1447-1452.
19. Johnson R.J., Stack M., Hazlewood S.A., Jones M., Blackmore C.G., Hu L.F., Rowe M. The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. J. Virol. 72:1998;4038-4048.
20. Kaye K.M., Izumi K.M., Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 90:1993;9150-9154.
21. Kaye K., Devergne O., Harada J., Izumi K., Yalamanchili R., Kieff E., Mosialos G. Tumor necrosis factor associated factor 2 is a mediator of NF-κB activation in latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. USA. 93:1996;11085-11090.
22. Kieser A., Kilger E., Gires O., Ueffing M., Kolch W., Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-jun N-terminal kinase cascade. EMBO J. 16:1997;6478-6485.
23. Klein G. Epstein-Barr virus strategy in normal and neoplastic B-cells. Cell. 77:1994;791-793.
24. Knecht H., Bachmann E., Brousset P., Sandvej K., Nadal D., Bachmann F., Odermatt B.F., Delsol G., Pallesen G. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood. 82:1993;2937-2942.
25. Laherty C., Hu H., Opipari A., Wang F., Dixit V. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J. Biol. Chem. 267:1992;24157-24160.
26. Martin J.M., Veis D., Korsmeyer S.J., Sugden B. Latent membrane protein of the Epstein-Barr virus induces cellular phenotypes independently of expression of bcl-2. J. Virol. 67:1993;5269-5278.
27. Meggetto F., Brousset P., Selves J., Delsol G., Mariame B. Reed-Sternberg cells and "bystander" lymphocytes in lymph nodes affected by Hodgkin's disease are infected with different strains of Epstein-Barr virus. J. Virol. 71:1997;2547-2549.
28. Mehl A.M., Fischer N., Rowe M., Hartmann F., Daus H., Trumper L., Pfreundschuh M., Mueller-Lantzsch N., Grässer F.A. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus (EBV) encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma. Int. J. Cancer. 76:1998;194-200.
29. Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:1973;190-194.
30. Miller W.E., Mosialos G., Kieff E., Raab-Traub N. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-κB. J. Virol. 71:1997;586-594.
31. Mitchell T., Sugden B. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:1995;2968-2976.
32. Moorthy R.K., Thorley-Lawson D. Processing of the Epstein-Barr virus encoded latent membrane protein p63/LMP. J. Virol. 64:1990;829-837.
33. Moorthy R.K., Thorley-Lawson D. All three domains of the Epstein-Barr virusencoded latent membrane protein LMP-1 are required for transformation of rat1 fibroblasts. J. Virol. 67:1993;1638-1646.
34. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
35. Mullenbach R., Lagoda P.J., Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 5:1989;391.
36. Okano M., Thiele G.M., Davis J.R., Grierson H.L., Purtilo D.T. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin. Microbiol. Rev. 1:1988;300-312.
37. Rickinson, A.B., Kieff, E., 1995. Epstein-Barr virus. In: Fields, B.N., Knipe, D.M., Howley, P.M. (Eds.), Virology. Raven Press, New York, pp. 2397-2446.
38. Roemer K., Mueller-Lantzsch N. p53 transactivation domain mutant Q22, S23 is impaired for repression of promoters and mediation of apoptosis. Oncogene. 12:1996;2069-2079.
39. Rowe M., Evans H., Young L., Hennessy K., Kieff E., Rickinson A. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus transformed cells. J. Gen. Virol. 68:1987;1575-1586.
40. Rowe M., Peng-Pilon M., Huen D., Hardy R., Croom-Carter D., Lundgren E., Rickinson A. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell specific response that is delayed relative to NF-κB activation and to induction of cell surface markers. J. Virol. 68:1994;5602-5612.
41. Sandvej K., Gratama J.W., Munch M., Zhou X.G., Bolhuis R.L., Andresen B.S., Gregersen N., Hamilton-Dutoit S. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood. 90:1997;323-330.
42. Stein B., Angel P., van Dam H., Ponta H., Herrlich P., van der Eb A., Rahmsdorf H.J. Ultraviolet-radiation induced c-jun gene transcription: two AP-1 like binding sites mediate the response. Photochem. Photobiol. 55:1992;409-415.
43. Sung N.S., Edwards R.H., Seillier-Moiseiwitsch F., Perkins A.G., Zeng Y., RaabTraub N. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int. J. Cancer. 76:1998;207-215.
44. Yao Q.Y., Tierney R.J., Croom-Carter D., Dukers D., Cooper G.M., Ellis C.J., Rowe M., Rickinson A.B. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J. Virol. 70:1996;4884-4894.